Ibandronate Sodium Injection
Ibandronate Sodium Monohydrate 3.375mg
Injections · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.
MFDS item code 201306429 · Approved 2013.03.22 · Insurance code 641807081
Treatment of osteoporosis in postmenopausal women
Used to treat osteoporosis that tends to occur in postmenopausal women. This medication helps increase bone density and reduce the risk of fractures. It helps maintain healthy bones by preventing bone loss due to menopause. Therefore, it is used for the treatment of osteoporosis in postmenopausal women.
Administer 3mg by intravenous injection over 15 - 30 seconds once every 3 months. Patients should take calcium and vitamin D supplements as an adjunct. If a dose is missed on the scheduled dosing date, administer the injection as soon as possible and continue regular dosing at 3-month intervals from then on. Patients with hepatic impairment No dosage adjustment is necessary. Patients with renal impairment No dosage adjustment is necessary for patients with mild or moderate renal impairment whose serum creatinine is ≤ 200 µmol/L (2.3mg/dL) or whose creatinine clearance is ≥ 30ml/min. Administration of this medicine is not recommended for patients whose serum creatinine is > 200 µmol/L (2.3mg/dL) or whose creatinine clearance is < 30ml/min because clinical experience is insufficient. Older adults No dosage adjustment is necessary.
Efficacy and safety in children aged 18 years or younger have not been studied.
This medication must be administered strictly by intravenous injection; care must be taken to avoid injecting incorrectly around arteries or veins, as this may cause tissue damage. Do not use in individuals with an allergy to this drug or its components, or those with untreated hypocalcemia. Adverse reactions may occur during treatment, primarily gastrointestinal disturbances, musculoskeletal pain, fatigue, headache, skin rash, etc. Upon initial administration, flu-like symptoms such as joint pain, muscle pain, fever, and chills may occur temporarily; however, they are generally mild and resolve without treatment. This medication may temporarily lower serum calcium levels, so calcium levels should be maintained within normal ranges before administration, and it is important to take sufficient calcium and vitamin D. Patients with poor oral hygiene or those undergoing cancer treatment may have an increased risk of osteonecrosis of the jaw, hence dental examination and preventive treatment are needed before administration. It is advisable to avoid excessive dental treatment during administration; if osteonecrosis of the jaw occurs, professional consultation is necessary as the condition may worsen. Additionally, long-term use of this medication may lead to atypical fractures in the femur or other bones, so if pain occurs in the thigh or groin, notify a doctor immediately. This medication is excreted by the kidneys, therefore patients with impaired kidney function should undergo regular examinations, and renal and liver function should be closely monitored in case of overdose. Women who are pregnant or breastfeeding should not use this medication as its safety has not been established. The safety and efficacy in children and adolescents under 18 years of age have not been confirmed. This medication should not be mixed with calcium-containing solutions or other intravenous drugs, and needles and syringes should not be reused and must be disposed of safely. Serious allergic reactions such as anaphylaxis may occur during the administration of this medication, so if any adverse symptoms appear, discontinue administration immediately and seek appropriate treatment.
Gastritis, diarrhea, abdominal pain, indigestion, nausea, constipation, musculoskeletal pain, joint pain, muscle pain, influenza-like illness, fatigue, headache, rash, bone pain, weakness, injection site reaction, phlebitis, thrombophlebitis, hypersensitivity reaction, angioedema, facial swelling, edema, urticaria, osteonecrosis of the jaw and external auditory canal, uveitis, episcleritis, scleritis, anaphylactic reaction, shock, exacerbation of asthma, Stevens-Johnson syndrome, erythema multiforme, bullous dermatitis, atypical electronic lower extremity fracture, intertrochanteric femoral fracture, dizziness, optic atrophy, lower motor neuron lesion, tremors, unspecified gastrointestinal disease, benign gastrointestinal neoplasm, dental pain, hyperventilation, cough, shortness of breath, laryngitis, vaginitis, menopausal symptoms, insomnia, anxiety, tinnitus, hearing loss, hypothyroidism, lipoma, ocular hemorrhage, heart failure, urinary disorders, hematuria, skin exfoliation, multiple organ failure, death, sensory impairment, acute renal failure
Not everyone experiences these, and they can vary from person to person.
Store this medication in a sealed container to avoid exposure to air. It is advisable to maintain room temperature between 1 to 30 degrees Celsius. This storage will help preserve the efficacy of the medication for a longer period.
An injection in a colorless, transparent solution contained in a colorless, transparent glass prefilled syringe with a single-use injection needle attached.
3ml x 1 vial
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ibandronate Sodium Monohydrate 3.375mg
Injections · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Ibandronate Sodium Monohydrate 3.375mg
Solution · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.